Free Trial

Shuttle Pharmaceuticals (SHPH) Insider Trading & Ownership

Shuttle Pharmaceuticals logo
$3.59 +0.11 (+3.16%)
Closing price 09/12/2025 03:59 PM Eastern
Extended Trading
$3.49 -0.10 (-2.79%)
As of 09/12/2025 05:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Shuttle Pharmaceuticals (NASDAQ:SHPH) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.60%
Number Of
Insiders Buying
(Last 3 Years)
0
Number Of
Insiders Selling
(Last 3 Years)
3
Amount Of
Insider Selling
(Last 3 Years)
$11.55K
Get SHPH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Shuttle Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SHPH Insider Buying and Selling by Quarter

Shuttle Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/13/2023Bette JacobsDirectorSell166$11.50$1,909.00  
12/29/2022Hoek Michael VanderCFOSell89$40.00$3,560.00  
12/29/2022Peter DritschiloCOOSell152$40.00$6,080.00  
(Data available from 1/1/2013 forward)

SHPH Insider Trading Activity - Frequently Asked Questions

The list of insiders at Shuttle Pharmaceuticals includes Bette Jacobs, Hoek Michael Vander, and Peter Dritschilo. Learn more on insiders at SHPH.

12.60% of Shuttle Pharmaceuticals stock is owned by insiders. Learn more on SHPH's insider holdings.

The following insider sold SHPH shares in the last 24 months: Bette Jacobs ($1,909.00).

Insiders have sold a total of 166 Shuttle Pharmaceuticals shares in the last 24 months for a total of $1,909.00 sold.

Shuttle Pharmaceuticals Key Executives

  • Dr. Anatoly Dritschilo M.D. (Age 80)
    Co-Founder, CEO & Chairman of the Board
    Compensation: $399.18k
  • Mr. Peter Dale Dritschilo M.B.A. (Age 55)
    M.D., President & COO
    Compensation: $314.01k
  • Dr. Milton Brown CSC (Age 59)
    M.D., Ph.D., Co-Founder & Director
  • Mr. Michael P. Vander Hoek (Age 64)
    CFO and VP of Operations & Regulatory
    Compensation: $302.53k
  • Dr. Tyvin A. Rich M.D. (Age 76)
    Chief Clinical Officer & Chief Medical Officer
    Compensation: $263.23k
  • Dr. Mira Jung Ph.D. (Age 75)
    Co-Founder & Chief Scientific Officer for Biology
  • Mr. Gene Jung Esq.
    General Counsel


This page (NASDAQ:SHPH) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners